| Literature DB >> 26733007 |
Cécile Aenishaenslin1,2, Pascal Michel3,4, André Ravel5, Lise Gern6, Jean-Philippe Waaub7, François Milord8, Denise Bélanger9,10.
Abstract
BACKGROUND: Lyme disease control strategies may include tick control interventions in high risk areas. Public authorities may be interested to assess how these types of interventions are perceived by the public which may then impact their acceptability. The aims of this paper are to compare socio-cognitive factors associated with high acceptability of tick control interventions and to describe perceived issues that may explain their low acceptability in populations living in two different regions, one being an endemic region for LD since the last 30 years, the Neuchâtel canton, in Switzerland, and another where the disease is emerging, the Montérégie region, in Canada.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26733007 PMCID: PMC4700560 DOI: 10.1186/s12889-015-2629-x
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Levels of acceptability of tick control interventions in Neuchâtel and Montérégie. This figure shows the proportions of respondents with high acceptability (scores of 4 or 5) for eight tick control interventions against LD in Neuchâtel (n = 413) and Montérégie (n = 401)
Factors associated with high acceptability (scores of 4 or 5) of landscaping, acaricide, rodent vaccination and fencing (Logistic regressions)
| Factors associated with high acceptability of | ||||
| Montérégie ( | Neuchâtel ( | |||
| OR | 95 % CI | OR | 95 % CI | |
| Age 18–34 years | 0.32 | (0.09–1.10) | 0.51 | (0.13–1.98) |
| 35–54 years | 0.77 | (0.39–1.54) | 2.70 | (0.93–7.88) |
| 55+ yr R | 1 | na | 1 | na |
| Education (University) | 0.83 | (0.39–1.76) | 0.36 | (0.15–0.88)* |
| Knowledge of LD | 1.02 | (0.42–2.48) | 0.72 | (0.31–1.67) |
| Risk perception | 1.64 | (1.05–2.57)* | 2.88 | (1.45–5.74)** |
| Perceived efficacy | 16.31 | (8.50–31.28)*** | 37.48 | (13.95–100.71)*** |
| Factors associated with high acceptability of the use of | ||||
| Montérégie ( | Neuchâtel ( | |||
| OR | 95 % CI | OR | 95 % CI | |
| Age 18–34 years | 0.16 | (0.05–0.49)*** | 0.47 | (0.18–1.23) |
| 35–54 years | 0.98 | (0.54–1.80) | 0.85 | (0.37–1.95) |
| 55+ yr R | 1 | na | 1 | na |
| Knowledge of LD | 0.47 | (0.20–1.07) | 0.33 | (0.16–0.69)** |
| Risk perception | 1.60 | (1.08–2.36)* | 1.48 | (0.88–2.50) |
| Perceived efficacy | 20.89 | (11.41–38.22)*** | 12.28 | (6.03–24.99)*** |
| Factors associated with high acceptability of | ||||
| Montérégie ( | Neuchâtel ( | |||
| OR | 95 % CI | OR | 95 % CI | |
| Education (University) | 2.01 | (1.11–3.66)* | 0.69 | (0.39–1.20) |
| Knowledge of LD | 0.67 | (0.32–1.42) | 1.05 | (0.61–1.81) |
| Risk perception | 1.34 | (0.92–1.96) | 1.35 | (0.91–2.00) |
| Perceived efficacy | 21.37 | (12.15–37.58)*** | 17.37 | (9.69–31.15)*** |
| Factors associated with high acceptability of | ||||
| Montérégie ( | Neuchâtel ( | |||
| OR | 95 % CI | OR | 95 % CI | |
| Age 18–34 years | 0.65 | (0.27–1.57) | 1.48 | (0.53–4.16) |
| 35–54 years | 0.56 | (0.31–1.03) | 2.60 | (1.04–6.48)* |
| 55+ yr R | 1 | na | 1 | Na |
| Knowledge of LD | 0.64 | (0.29–1.43) | 0.93 | (0.48–1.79) |
| Risk perception | 1.65 | (1.13–2.41)** | 1.07 | (0.68–1.68) |
| Perceived efficacy | 22,82 | (12.83–40.59)*** | 10,17 | (5.27–19.63)*** |
*p <0.05. **p < 0.01. ***p < 0.001
Distribution of participants by region for the five FGD
| Region | Focus groups (number of participants) | Descriptive characteristics of participants by region |
|---|---|---|
| Neuchâtel | Focus group 1 (7) | 22/22 (100 %) were aware of LD for more than one year |
| Focus group 2 (9) | 7/22 (27 %) had a high risk perception (global risk perception score ≥4) | |
| Focus group 3 (6) | 19/22 (86 %) had a high level of knowledge on LD | |
| Total = 22 | 3/22 (14 %) declared that they had LD in the past | |
| 17/22 (77 %) declared that they knew someone who has ever had LD | ||
| 16/22 (73 %) were women | ||
| Age of participants was distributed between 18 and more than 75 years old. | ||
| Montérégie | Focus group 4 (6) | 10/12 (83 %) were aware of LD for more than one year |
| Focus group 5 (6) | 6/12 (50 %) had a high risk perception (global risk perception score ≥4) | |
| Total = 12 | 7/12 (58 %) had a high level of knowledge on LD | |
| 0/12 (0 %) declared that they had LD in the past | ||
| 1/12 (8 %) declared that they knew someone who has ever had LD | ||
| 8/12 (67 %) were women | ||
| Age of participants was distributed between 25 and 64 years old |